Ownership history in MORGAN STANLEY · 41 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in ADAPTIMMUNE THERAPEUTICS PLC (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 3,666,061 | -566,207 | -13.4% | 0.00% | $477K | — |
| 2025 Q2 | ADDED | 4,232,268 | +1,516,321 | +55.8% | 0.00% | $1.0M | — |
| 2025 Q1 | ADDED | 2,715,947 | +1,391,083 | +105.0% | 0.00% | $535K | — |
| 2024 Q4 | REDUCED | 1,324,864 | -374,161 | -22.0% | 0.00% | $714K | — |
| 2024 Q3 | ADDED | 1,699,025 | +1,258,193 | +285.4% | 0.00% | $1.6M | — |
| 2024 Q2 | ADDED | 440,832 | +67,551 | +18.1% | 0.00% | $430K | — |
| 2024 Q1 | REDUCED | 373,281 | -1,583,377 | -80.9% | 0.00% | $590K | — |
| 2023 Q4 | REDUCED | 1,956,658 | -94,688 | -4.6% | 0.00% | $1.6M | — |
| 2023 Q3 | REDUCED | 2,051,346 | -25,826 | -1.2% | 0.00% | $1.6M | — |
| 2023 Q2 | REDUCED | 2,077,172 | -175,252 | -7.8% | 0.00% | $1.9M | — |
As of 2025 Q4 — sorted by position size